LXEO · Lexeo Therapeutics, Inc. · Webcasts, Transcripts & Audio
$2.76
+0.12 (+4.55%)
At close · Oct 19
Return incl. dividend (before tax)
Market Cap
$226.45M
Shares
82.05M
Volume · Oct 19
1.86M
Avg daily vol (3M)
1.29M
Lexeo Therapeutics, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Lexeo Therapeutics, Inc. (LXEO), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Conference
Investor event
2026-10-20
Lexeo Therapeutics, Inc. (LXEO) October 20, 2026 Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-09-22
Lexeo Therapeutics, Inc. (LXEO) Q2 2026 Earnings Call Transcript
Confident tone
LX2006 Pivotal Study Design (Sunrise FA2)
Regulatory Pathway and FDA Engagement
LX2006 Efficacy and Safety Data (Phase 1/2)
Diluted EPS
$-0.30
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-09-15
Lexeo Therapeutics, Inc. (LXEO) September 15, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-06-15
Lexeo Therapeutics, Inc. (LXEO) Q1 2026 Earnings Call Transcript
Confident tone
Cardiac efficacy data (LVMI and troponin)
LX2006 Sunrise FA2 pivotal trial design
Regulatory pathway and FDA engagement
Diluted EPS
$-0.25
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-01-12
Lexeo Therapeutics, Inc. (LXEO) Q4 2025 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Showing 1–5 of 5 webcasts
Key facts
CIK
1907108
CUSIP
52886X107
13F (30d)
10 filings
10 filers
Visit website
Investor relations